Active Shortage

TOBRAMYCIN FOR INJECTION U.S.P.

STERIMAX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TOBRAMYCIN FOR INJECTION U.S.P. in Canada?

Yes. TOBRAMYCIN FOR INJECTION U.S.P. 1.2G has an active shortage reported to Health Canada (last updated March 29, 2019).

Why is TOBRAMYCIN FOR INJECTION U.S.P. not available?

The reason the manufacturer reported: Delay in shipping of the drug.

When will TOBRAMYCIN FOR INJECTION U.S.P. be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products · 1 same form & route

Affected strength1.2G

Report last updated2019-03-29

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TOBRAMYCIN FOR INJECTION

FRESENIUS KABI CANADA LTD

1.2G · DIN 00533688

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

TOBRAMYCIN INJECTION USP

SANDOZ CANADA INCORPORATED

10MG · DIN 02241209

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TOBREX

NOVARTIS PHARMACEUTICALS CANADA INC

0.3% · DIN 00513962

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

TOBI

BGP PHARMA ULC

300MG · DIN 02239630

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

TOBRAMYCIN INJECTION, USP

FRESENIUS KABI CANADA LTD

40MG · DIN 02230640

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

SANDOZ TOBRAMYCIN

SANDOZ CANADA INCORPORATED

0.3% · DIN 02241755

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02285150

Strength

1.2G

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

TOBRAMYCIN

Tier

Unrated

Last Updated

2019-03-29

Reason for Shortage

Delay in shipping of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890